Clinical Trial Update: Link Between Reduction of Suicide Ideation by Esketamine in Add-On and Initial Levels of Psychological Pain and Anhedonia

View source ↗

Summary

A clinical trial update examines whether adding esketamine to ongoing treatment reduces suicidal ideation in major depressive disorder. It also analyzes links t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SPRAVATO (ESKETAMINE HYDROCHLORIDE)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Depression - Major Depressive Disorder, Depression Disorder | Status: ACTIVE_NOT_RECRUITING